COVID-19: Top 8 Pharma Companies to Keep an Eye On

As COVID-19 continues to spread across the globe and wreak havoc, pharmaceutical and biotech companies are working on potential vaccines at a pace never seen before raising hopes that a proven effective drug could be available earlier than expected.

The good news is:

As experts continue to learn more about this novel coronavirus, they are one step closer to a breakthrough in immunizing the human race against the deadly disease.

 

Perhaps unsurprisingly…

Pharmaceutical companies are taking center stage not only in the fight against COVID-19 but also in the financial sector as traders are looking for potential investment opportunities.

 

Look:

If you’re interested in exploring pharma and biotech stocks and add them to your trading portfolio then here are some of the most notable companies that we highly recommend for you to keep an eye on:

 

1. Regeneron Pharmaceuticals

Regeneron Pharmaceuticals reported that is actively working on testing Kevzara, a rheumatoid arthritis (RA) drug in treating those who are infected by the virus.

What is it?

The drug helps reducing inflammation and other symptoms associated with RA and the idea is that this could also provide relief by regulating the inflammatory response in the lungs of COVID-19 patients.

Additionally…

It has partnered with Sanofi in doing a second phase 2/3 trial of the drug.

 

Trusted and Regulated Brokers Where You Can Trade Regeneron CFDs
etoro logo

Read Review

Regeneron Page

75% of retail CFD accounts lose money.

plus500 logo

Read Review

Regeneron Page

76.4% of retail CFD accounts lose money.

plus500 logo

Read Review

Regeneron Page

2. Gilead Sciences

This research-based biopharmaceutical company is among the first to work on experimental drugs that could demonstrate the potential to be a safe and effective treatment option.

And the good news is…

Positive drug results for its antiviral drug Remdesivir showed promising activity against the new coronavirus.

Fact:

This nucleotide analogue prodrug was also used for the treatment of patients who are infected with the deadly Ebola virus.

 

Trusted and Regulated Brokers Where You Can Trade Gilead CFDs
etoro logo

Read Review

Gilead Page

75% of retail CFD accounts lose money.

plus500 logo

Read Review

Gilead Page

76.4% of retail CFD accounts lose money.

plus500 logo

Read Review

Gilead Page

3. Amgen

This pharma giant has partnered with Seattle-based Adaptive Biotechnologies in developing fully human neutralizing antibodies that can be used to prevent or treat the novel coronavirus.

How does it work?

With this mutually exclusive collaboration, screening of blood samples from recovered COVID-19 patients will be done for the purpose of identifying which naturally occurring antibodies in the human immune system can be used in neutralizing the virus.

In detail:

Amgen will handle the development and production of antibody therapy development and Adaptive Biotechnologies will do its part in identifying virus-neutralising antibodies in tackling the pandemic.

 

Trusted and Regulated Brokers Where You Can Trade Amgen CFDs
etoro logo

Read Review

Amgen Page

75% of retail CFD accounts lose money.

plus500 logo

Read Review

Amgen Page

76.4% of retail CFD accounts lose money.

plus500 logo

Read Review

Amgen Page

4. GlaxoSmithKline

This multinational pharma company has made several collaborations with other drugmakers and research groups in developing vaccine candidates against the virus.

Its collaboration with Sanofi made headlines as it brings together two of the world’s biggest vaccine companies.

What’s the deal?

Via the combination of their technologies and expertise, they aim to develop an adjuvanted vaccine and are expecting to initiate phase I clinical trials by the second half of 2020 and are targeting to have the vaccine available by the second half of 2021.

 

Trusted and Regulated Brokers Where You Can Trade GlaxoSmithKline CFDs
etoro logo

Read Review

GlaxoSmithKline Page

75% of retail CFD accounts lose money.

plus500 logo

Read Review

GlaxoSmithKline Page

76.4% of retail CFD accounts lose money.

5. Johnson & Johnson

American multinational corporation Johnson & Johnson (J & J) has made production deals with a network of manufacturing partners in order to ramp up its capacity as drugmakers are racing to launch potential vaccines as fast as possible.

It has already made a deal with New Jersey-based Emergent BioSolutions with a target of phase 1 trials by September 2020. It also partnered with Catalent to boost the company’s facility in Bloomington, Indiana.

Additionally…

It has collaborated with the Biomedical Advanced Research and Development Authority (BARDA) in screening existing antiviral medications and experimental vaccine candidates.

 

Trusted and Regulated Brokers Where You Can Trade Johnson & Johnson CFDs
etoro logo

Read Review

J & J Page

75% of retail CFD accounts lose money.

plus500 logo

Read Review

J & J Page

76.4% of retail CFD accounts lose money.

plus500 logo

Read Review

J & J Page

6. Roche

This Swiss multinational healthcare company is evaluating its proprietary medicine called Actemra, a rheumatoid arthritis drug which was reported to be a potential treatment in managing deadly immune complications for patients that are severely affected by the virus such as pneumonia.

The company is also planning to launch it own antibody test which will be based on intravenous blood draws that were taken by doctors and nurses.

 

Trusted and Regulated Brokers Where You Can Trade Roche CFDs
etoro logo

Read Review

Roche Page

75% of retail CFD accounts lose money.

plus500 logo

Read Review

Roche Page

76.4% of retail CFD accounts lose money.

7. Takeda Pharmaceutical

Japan’s largest drug manufacturer and CSL Behring has formed an alliance with top plasma firms including Biotest, Octapharma, BPL and LFB in quickly developing an unbranded plasma-based COVID-19 treatment.

With this collaboration of industry experts, they aim to develop an efficient polyclonal hyperimmune immunoglobulin therapy that will treat serious coronavirus complications and ramp up the potential supply.

This project is also inviting other institutions including government and academic initiatives.

 

Trusted and Regulated Brokers Where You Can Trade Takeda CFDs
plus500 logo

Read Review

Takeda Page

76.4% of retail CFD accounts lose money.

8. Sanofi

As we mentioned earlier, Sanofi is collaborating with other top pharmaceutical firms including Regeneron and GlaxoSmithKline in researching and developing products as potential treatments for COVID-19 patients including vaccines and testing kits.

And did you know?

Majority of Sanofi’s huge range products are listed as essential medicines.

 

Trusted and Regulated Brokers Where You Can Trade Sanofi CFDs
etoro logo

Read Review

Sanofi Page

75% of retail CFD accounts lose money.

plus500 logo

Read Review

Sanofi Page

76.4% of retail CFD accounts lose money.

 

 

We will be happy to hear your thoughts

      Leave a reply